Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PEB | Ann: ASX 3B documents lodged | 17/07/25 | 0 | 126 | |||
|
|||||||
PEB | Ann: Pacific Edge Opens $5.0 Million Share Purchase Plan | 17/07/25 | 0 | 117 | |||
|
|||||||
PEB | Ann: Notice of Annual Shareholders' Meeting | 17/07/25 | 0 | 81 | |||
|
|||||||
PEB | Ann: Pacific Edge - Cleansing Notice | 17/07/25 | 0 | 89 | |||
|
|||||||
PEB | Ann: Q1 26 Cxbladder Demand Resilient Despite Coverage Loss | 14/07/25 | 0 | 154 | |||
|
|||||||
PEB | Ann: Annual Report 2025 | 30/06/25 | 0 | 190 | |||
|
|||||||
PEB | Ann: Chair to Seek Re-Election; Director Nominations | 16/06/25 | 0 | 159 | |||
|
|||||||
PEB | Ann: PEB - Waiver from NZX Listing Rule 4.19.1 | 12/06/25 | 0 | 152 | |||
|
See All Discussions